Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Hani B. Babiker"'
Publikováno v:
Cancer Research. 80:CT265-CT265
The checkpoint inhibitors pembrolizumab, nivolumab as monotherapy, and nivolumab in combination with ipilimumab are approved in the US for treatment of patients with previously treated microsatellite instability-high (MSI-high) or mismatch repair-def